CardioComm Solutions, Inc.
TSX VENTURE : EKG

CardioComm Solutions, Inc.

June 20, 2008 13:53 ET

CardioComm Solutions, Inc. to Hold Annual General Meeting in Victoria, British Columbia on June 23, 2008

VICTORIA, BRITISH COLUMBIA--(Marketwire - June 20, 2008) - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company") will be holding its annual general meeting of shareholders in Victoria, British Columbia on June 23, 2008. A notice of the meeting, a management information circular and a form of proxy have been mailed to the shareholders of the Company.

At the meeting, shareholders will be asked to appoint auditors of the Company for the ensuing year and to elect the board of directors. With the exception of Mr. Stephen Martin and Mr. Brad Harlow, all of the Company's current directors will be seeking re-election. Mr. Martin, who has been the Company President & CEO, has agreed to step down effective immediately. Dr. Anatoly Langer, Chairman of the board of directors, will act as CEO of the Company on an interim basis until a new CEO is appointed.

Dr. Langer said, "I would like to thank Mr. Harlow and Mr. Martin for their service to the Company as directors and, in the case of Mr. Martin, as President and CEO. In particular, I would like to thank Stephen for his many years of dedicated service to CardioComm. On behalf of the board, I wish Stephen the very best in his future endeavors and look forward to calling upon him for his counsel in the future."

The Company also announced that Dr. Galina Langer has advised that she will not be standing for election as director of the Company at the upcoming annual general meeting. Dr. Langer informed the Company that her other commitments prevent her from acting as director of the Company. As a result of this, the number of directors of the Company for the ensuing year will be set at six and votes cast in favour of the election of Dr. Galina Langer will be disregarded.

About CardioComm Solutions, Inc.

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (EKGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time EKG viewer. CardioComm is the first company to provide a real-time means of viewing EKGs over a network (LAN, WAN or Internet). This tool enables EKGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global EKG Management System (GEMS™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.

On behalf of the Board of Directors of CardioComm Solutions, Inc.

Anatoly Langer, MD. Chairman of the Board

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • CardioComm Solutions, Inc.
    Ian Klassen
    1-877-744-1122